BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35229971)

  • 1. NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.
    Morganti C; Ito K; Yanase C; Verma A; Teruya-Feldstein J; Ito K
    EMBO Rep; 2022 May; 23(5):e54262. PubMed ID: 35229971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia.
    Khanna-Gupta A; Abayasekara N; Levine M; Sun H; Virgilio M; Nia N; Halene S; Sportoletti P; Jeong JY; Pandolfi PP; Berliner N
    J Biol Chem; 2012 Sep; 287(39):32728-37. PubMed ID: 22851180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.
    Sportoletti P; Grisendi S; Majid SM; Cheng K; Clohessy JG; Viale A; Teruya-Feldstein J; Pandolfi PP
    Blood; 2008 Apr; 111(7):3859-62. PubMed ID: 18212245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
    Shiseki M; Kitagawa Y; Wang YH; Yoshinaga K; Kondo T; Kuroiwa H; Okada M; Mori N; Motoji T
    Leuk Lymphoma; 2007 Nov; 48(11):2141-4. PubMed ID: 17990177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
    Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
    Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal cytoplasmic dyslocalisation and/or reduction of nucleophosmin protein level rarely occurs in myelodysplastic syndromes.
    Ishikawa Y; Xu J; Sakashita G; Urano T; Suzuki T; Tomita A; Kiyoi H; Nakamura S; Naoe T
    Leuk Lymphoma; 2008 Dec; 49(12):2359-64. PubMed ID: 19052985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia and Myelodysplastic Syndromes with
    Sill H; Zebisch A; Haase D
    Clin Cancer Res; 2020 Oct; 26(20):5304-5309. PubMed ID: 32816950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia.
    Mannelli F; Ponziani V; Bonetti MI; Bencini S; Cutini I; Gianfaldoni G; Scappini B; Pancani F; Rondelli T; Benelli M; Caporale R; Grazia Gelli AM; Peruzzi B; Longo G; Bosi A
    Exp Hematol; 2015 Oct; 43(10):869-879.e22. PubMed ID: 26101160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation.
    Akef A; McGraw K; Cappell SD; Larson DR
    PLoS Biol; 2020 Nov; 18(11):e3000920. PubMed ID: 33137094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
    Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Forghieri F; Nasillo V; Paolini A; Bettelli F; Pioli V; Giusti D; Gilioli A; Colasante C; Acquaviva G; Riva G; Barozzi P; Maffei R; Potenza L; Marasca R; Fozza C; Tagliafico E; Trenti T; Comoli P; Longo G; Luppi M
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S; Cai W; Liu Y
    Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
    Nemeckova S; Alexova-Zurkova K; Hainz P; Krystofova J; Mackova J; Roubalova K; Stastna-Markova M; Vrana M; Vydra J
    Curr Oncol; 2022 Apr; 29(5):2928-2934. PubMed ID: 35621629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
    Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
    Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
    Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
    J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.